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PreviewsAll roads lead to FoxO
Stress-activated kinases control metabolism by antagonizing the early steps of insulin signal transduction. Two papers
now demonstrate that Jnk, the prototypical stress-activated kinase, controls life span in Drosophila and C. elegans by
promoting phosphorylation of the forkhead protein FoxO (Oh et al., 2005; Wang et al., 2005). The findings provide yet
another mechanism by which metabolic and stress responses are integrated via phosphorylation of FoxO proteins.It has been known for decades that me- i
tabolism affects life span. But the genet- n
ics underlying this bafflingly simple ob- v
servation were sharply focused by the I
finding that the master regulator of both s
processes in the roundworm C. elegans t
is the insulin/IGF receptor ortholog, D
daf-2. Yet more surprising was that the r
life-prolonging and metabolic effects of d
loss-of-function mutations in daf-2 could e
be abrogated single-handedly by muta- r
tions of the forkhead protein daf-16, the t
ortholog of mammalian FoxO. Subse- p
quent investigations of FoxO function in b
mammals have revealed a dazzling array p
of functions for these proteins (Accili s
and Arden, 2004). This unfolding story is a
now enriched by two papers (Oh et al., i
2005; Wang et al., 2005) describing how s
FoxO is required for life span regulation n
by Jnk in Drosophila and C. elegans. Oh p
and colleagues, writing in the Proceed- r
ings of the National Academy of Sci- o
ences of the United States of America, d
show that Jnk promotes daf-16 (FoxO) d
activity to regulate life span and stress s
resistance in the roundworm. Genetic d
epistasis indicates that the Jnk pathway i
requires daf-16, and biochemical analy- c
ses show that activated Jnk phosphory- n
lates daf-16 and promotes its nuclear (
translocation. In the April 7 issue of Cell,
Wang and colleagues show that Jnk- a
dependent life span extension in Dro- n
sophila also requires dfoxo, as do eye t
development and attainment of appro- d
priate cell size. Interestingly, one of the c
mechanisms by which dfoxo regulates t
life span includes direct repression of e
ancestral insulin-producing neuroendo- o
crine cells, a mirror image of the effect H
of FoxO haploinsufficiency in mice to a
prop up pancreatic β cell function (Kita- s
mura et al., 2002). s
t
Phosphorylation as a permissive p
signal for Foxo activity w
The observation that dfoxo/daf-16 integ- l
rates several pathways affecting longev- tCELL METABOLISM : APRIL 2005 · VOL. 1 · COty via stress response genes is perhaps 2
cot, by itself, surprising. Jnks are acti-
tated by cytokines, including Tnfα and
gL1, and exposure to environmental in-
sults, including UV irradiation and oxida-
pive stress (Weston and Davis, 2002). In
erosophila, it has been shown that Jnk
degulates life span and resistance to oxi-
mative stress (Jasper et al., 2001). How-
pver, the link between Jnk and FoxO
legulation of life span and stress resis-
tance had not been reported. One as-
pect of these contributions meriting
road interest is that these authors pro-
Iose that phosphorylation is the “on”
Aignal, promoting Foxo nuclear import
dnd gene expression. It bears emphasiz-
ng that the main effect of insulin/IGF
ignaling on FoxO is to promote its
uclear export via Akt-dependent phos-
horylation. Essers and colleagues have
ecently shown that, in mammalian cells,
xidative stress promotes Jnk-depen-
ent FoxO4 phosphorylation at sites
istinct from the inhibitory Akt sites (Es-
ers et al., 2004). These sites appear to
irectly antagonize the effects of Akt-
nduced phosphorylation, which has
lassically been viewed as the “off” sig-
al required for FoxO nuclear exclusion
Figure 1).
Thus far, FoxO’s regulation of life span
nd stress resistance has been mecha-
istically ascribed to the competing ac-
ions of histone acetyltransferases and
eacetylases (HDACs) on FoxO translo-
ation and transcriptional activity. Here,
he plot thickens. In C. elegans, life span
xtension by daf-16 requires Sir2a, the
rtholog of mammalian NAD-dependent
FDACs, or Sirtuins. Mammalian FoxOs
are acetylated in response to oxidative
Utress, and oxidative stress has been
s
hown to promote nuclear retention. Sir- r
Puins are a puzzling component of this
tathway. There is disagreement as to
ohether Sirt1-dependent FoxO deacety-
g
ation is a positive or a negative regula- t
cor of FoxO activity (Accili and Arden,PYRIGHT © 2005 ELSEVIER INC.004). More importantly, it is not at all
lear whether Sirtuin activation or inhibi-
ion should be viewed as a therapeutic
oal. In this respect, the recent demon-
tration that Sirt1 promotes glucose
roduction in liver via Pgc1α (Rodgers
t al., 2005) should dictate caution in
esigning Sirt-based approaches to
etabolic control. But if Jnk-dependent
hosphorylation is permissive for acety-
ation-mediated nuclear translocation,
his would provide an additional ap-
roach to modulate FoxO activity.
nsulin resistance, Jnk, and FoxO
second aspect of these papers that
eserves to be emphasized is that FoxOigure 1. Jnk coordinates stress response and met-
bolic signaling via FoxO
pon stress-induced activation, Jnk phosphorylates
everal substrates that affect insulin signaling. The
ed hexagons indicate serine phosphorylation sites.
rominent among them are the Irs proteins, Akt, and
he insulin receptor. The addition of FoxO to the list
f Jnk substrates provides a mechanism tying to-
ether metabolism and stress response. However,
he extent to which FoxO1 participates in metabolic
ontrol by Jnk remains to be addressed.215
P R E V I E Wappears to be the main effector of Jnk w
psignaling, at least with respect to the
longevity phenotype. In metabolism, Jnk (
activation is known to be a mechanism r
of insulin resistance, and Jnk ablation in i
mice has profound effects on the sus- n
mceptibility to diabetes and obesity (Hiro-
sumi et al., 2002). The agreed-upon s
mechanism of Jnk inhibition of insulin c
wsignaling has thus far been considered
serine phosphorylation of Irs proteins, as o
well as other proximal elements of insu- t
vlin signaling, including Akt and possibly
the insulin receptor itself (White, 2003). F
There is little doubt that this mechanism i
is important. But the discovery that Jnk m
can exert some of its effects via FoxO t
introduces a new potential explanation e
for the ability of Jnk to cause insulin re- F
hsistance. This hypothesis will have to be
tested in appropriate model organisms. s
An interesting subplot emerges from i
the observation in the Wang et al. paper
that Jnk mutations affect dilp (insulin) M
production in a dfoxo-dependent manner. a
This observation ties together mecha- D
nistically three key factors in metabolic C
control: the paracrine control of insulin C
production by the insulin signaling path- N216Say, the role of oxidative stress in the
athogenesis of β cell failure in diabetes
A
so-called “glucose toxicity”), and the 4
egulation of these processes by FoxO
E
n the β cell (Kitamura et al., 2002). It S
gow remains to be seen whether in
ammals the metabolic and stress re- H
istance effects of Jnk can be both C
thalked up to increased FoxO activity or
hether the signaling pathways branch J
Cff downstream from Jnk. Regardless of
mhe outcome of further studies, the con-
ergence of multiple pathways onto K
BoxO underscores its prominent role
Kn metabolic control. The challenge re- 1
ains how to harness the protean func-
O
ions of this molecule to a therapeutic a
nd, bearing in mind that treading on (
4oxO to control metabolic disorders will
ave to be done gingerly, as both exces- R
Sive and defective FoxO functions prom-
t
se to stir up trouble.
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